Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
Wicherska-Pawłowska K, Wróbel T, Rybka J. · 2021
Read Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases. by Wicherska-Pawłowska K, Wróbel T, Rybka J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8704656.txt.
Description
Wicherska-Pawłowska, Wróbel, and Rybka review three receptor families that guard the innate immune system. These receptors spot patterns from germs and from damaged tissue. Toll-like receptors sit in cell membranes. NOD-like and RIG-I-like receptors work inside cells. Each family wakes signal chains that switch on defense genes.
The same system also helps watch for cancer. Natural and lab-made triggers for these receptors can kill malignant cells. They can draw killer immune cells into tumors. Such triggers are now tested as aids in cancer immune therapy. The review covers structure, signals, and control of each family. Blood diseases get focus as a treatment target.
Catalog record
| CREATOR | Wicherska-Pawłowska K, Wróbel T, Rybka J. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |